Medical Library

InspiraChamber® Valved Holding Chamber 

• M.Newhouse, I.Amirav, A.Halamish, B.Kelly, R.Labiris, R.Toddywala, P.Vasandani. InspiraChamber® With Soothermask®: A Unique Device With Optimized Particle Size Selectivity And Minimal Dead Space. ATS 2012. doi: 10.1164/ajrccm-conference.2012. 185.1_Meeting Abstracts. A5632. 

• M.Newhouse, I.Amirav, A.Halamish, M.Hossain, B.Kelly, V.Shukla, R.Toddywala, P.Vasandani. InspirAlert™ and SealVision™: Simple and Unique Optimized Biofeedback in an Improved MDI Aerosol Delivery System. ISAM 2013. doi: 10.1089/jamp.2013.00A1. 

• B.Kelly, M.Hossain, M.Newhouse, V.Shukla, R.Toddywala, P.Vasandani. In vitro Comparison of Aerosol Characteristics of Two HFA pMDI Formulations Used in Asthma and COPD with InspiraChamber® and AeroChamber Plus Flow-Vu®. ATS 2014  

• M.Newhouse, V.Shukla, R.Toddywala. Comparison of InspiraChamber® with InspiraMask® and Optichamber with LiteTouch Mask: Aerosol Characteristics and Mask Volume. ATS 2016

• R.Toddywala, M.Newhouse, V.Shukla, P.Goldman. Simultaneous administration of O2 and prescribed aerosol medication via oxygen mask and InspiraChamber® Anti-Static Valved Holding Chamber. ATS 2018.  

SootherMask®/InspiraMask® 

• I.Amirav, A.Luder, A.Chlichel, et al. Lung aerosol deposition in suckling infants. Arch Dis Child 2012. doi: 10.1136/archdischild-2011-301236. 

• I.Amirav, A.Luder, A.Halamish, D.Raviv, R.Kimmel, M.Newhouse. Evidence Based Design of Facemasks for Children Using Computerized 3D Face Analysis. ATS 2012. doi: 10.1164/ajrccm-conference.2012.185.1_MeetingAbstracts.A5628. 

• I.Amirav, A.Halamish, M.Newhouse. Nasal Aerosol Delivery to the Lower Respiratory Tract May be Superior to Oral Delivery in Infants/Toddlers. CIPP 2012 

• M.Newhouse, I.Amirav. SootherMask®: A Unique Contoured, Low Dead Space Mask for Successful Delivery of Inhaled Medication to Infants. ATS 2013. doi: 10.1164/ajrccm-conference.2013.187.1_MeetingAbstracts.A4111. 

• I.Amirav, M.Newhouse, A.Luder, A.Halamish, H.Omar, M.Gorenberg. Aerosol Delivery to Infants ‘Without Tears’ – Back to Sleep. ATS 2013 

• I.Amirav, A.Borojeni, A.Halamish, M.Newhouse, L.Golshahi. Nasal Versus Oral Aerosol Delivery to the “Lungs” in Infants and Toddlers. Pediatric Pulmonology 2014. Wiley Periodicals. doi: 10.1002/ppul.22999. 

• I.Amirav, M.Newhouse, et al. Feasibility of aerosol drug delivery to sleeping infants: a prospective observational study. BMJ Open 2014;4:e004124 doi:10.1136/bmjopen-2013-004124. 

• I.Amirav, M.Diechman, A.Halamish, A.Luder, C.Marzuk, M.Newhouse. Computerized Dead Space Volume Measurement of Facemasks Applied to Digitally Simulated Faces. ATS 2014 

• I.Amirav, A.Luder, A.Halamish, C.Marzuk, M.Daitzchman, M.Newhouse. Computerized Dead Space Volume Measurement of Face Masks Applied to Simulated Faces. Respiratoy Care. September 2015, Vol 60 No 9. 

• I.Amirav, A.Halamish, M.Gorenberg, H.Omar, M.Newhouse. Realistic Face Model Surface Improves Pediatric in-vitro Aerosol Studies. ISAM 2015. 

I-BAN™ 

• R.Toddywala, S.Bhardwaj, R.Condos, G.Smaldone. Formulation and Aerosol Characterization of Select Aminoglycoside- and Fluoroquinolone-Class Antibiotics in a Proprietary Breath Actuated Nebulizer™ and In Vivo Pharmacokinetics in a Preclinical Mouse Model. ATS formulation Poster 2016. 

• G.Smaldone, A.Gowda, R.Toddywala, V.Shukla. Novel Jet Nebulizer / Holding Chamber for Drug Delivery to the Deep Lung. ERS 2016 

• R.Toddywala, V.Shukla, M.Newhouse. Aerosol Characteristics of a Unique Breath Actuated Nebulizer™. ERS 2017 

• R.Toddywala, V.Shukla, M.Newhouse. I-BAN™, a Unique breath-actuated, small volume, jet nebulizer vs AEII: aerosol characterization, total dose output and Respirable fraction. ISAM 2017. 

• R.Toddywala, V.Shukla, A.Hande, M.Newhouse. I-BAN™, a unique breath-actuated, small volume, jet nebulizer vs AE II: aerosol charactertization in continuous and breath-actuated mode. ISAM 2018. 

i-NEB Mini™ 

• J.Samuel, G.Smaldone. Maximizing Deep Lung Deposition in Healthy and Fibrotic Subjects During Jet Nebulization. DOI: 10.1089/jamp.2019.1552 

i-AIRE™ 

• R.Toddywala, V.Shukla, A.Hande, G.Smaldone. Aerosol delivery of inhaled Vancomycin during mechanical ventilation using i-VENT™ System, a unique small volume, breath enhanced jet nebulizer. ISAM 2019 

• R.Toddywala, V.Shukla, A.Hande, G.Smaldone. Aerosol Delivery of Inhaled Drugs during Mechanical Ventilation using i-AIRE™ System, a Unique Small Volume, Breath Enhanced Jet Nebulizer. ATS 2020 

Interferon gamma 1b 

• R.Condos, W.Rom, N.Schluger. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-g via aerosol. Lancet. 1997 May 24;349(9064):1513-5. 

• Kim J, Ferrara G, Bao Y, Rom WN, Brown S, Condos R. Aerosol Interferon-gamma treatment in a group of patients with Idiopathic Pulmonary Fibrosis. . Am J of Respir and Crit Care Med 2003. 171:A346 

• R.Condos, F.Hull, N.Schluger, et al. Regional Deposition of Aerosolized Interferon-g in Pulmonary Tuberculosis. CHEST 2004; 125:2146-2155. 

• R.Dawson, R.Condos, D.Tse, et al. Immunomodulation with Recombinant Interferon-gamma1b in Pulmonary Tuberculosis. 2009. PLoS ONE 4(9): e6984. doi:10.1371/journal.pone.0006984. 

• K.Diaz, S.Skaria, K.Harris, et al. Delivery and safety of inhaled interferon-γ in idiopathic pulmonary fibrosis. J Aerosol Med Pulm Drug Deliv. 2012 Apr; 25(2):79-87. doi: 10.1089/jamp.2011.0919. 

• G.Smaldone, R.Condos. Interferon-γ and Idiopathic Pulmonary Fibrosis: Why Pulmonary Targeting May be an Answer. Respiratory Drug Delivery 2012, Vol 1, pp 39-50. 

• S.Skaria, J.Yang, R.Condos, G.Smaldone. Clinical Endpoints Following Inhaled Interferon in Idiopathic Pulmonary Fibrosis (IPF). J Aerosol Med Pulm Drug Deliv. 2013 Apr; 26(2):A49-A50. id: 335152.  

• N.MacIntyre, S.Bhardwaj, R.Toddywala. Aerosol Delivery of an Immunomodulator (Interferon – γ1b) within Mouse Lungs. ERS 2015 

• R.Toddywala, S.Bhardwaj, R.Condos, G.Smaldone. Aerosolized Treatments for Multi-Drug Resistant Tuberculosis: Pharmacokinetics of Selected Antibiotics following Lung Deposition in a Mouse Model. Parma 2015 (PK Poster) 

• R.Toddywala, S.Bhardwaj. Aerosolized Treatments for Multi-Drug Resistant Tuberculosis. Formulation and Aerosolized Delivery Characterization of Aminoglycoside and Fluoroquinolone –Class Antibiotics. Parma Formulation Poster 2015. 

• P.Kanth, C.Alaienia, G.Smaldone. Nebulized Mannitol, Particle Distribution, and Cough in Idiopathic Pulmonary Fibrosis. Respir Care 2018;63(11):1407–1412

• J Samuel, Smaldone, Maximizing Deep Lung Deposition in Healthy and Fibrotic Subjects During Jet Nebulization, J Aerosol Medicine and Pulmonary Drug Delivery, 33 (2) 2020, 108–115.